BUZZ-U.S. STOCKS ON THE MOVE-Synta Pharma, Lorillard, BioCryst, Insmed
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were lower on Tuesday, indicating a modest retreat from the previous session's rally, including the strongest session for the Dow in more than a month. Dow Jones industrial average e-mini futures were down 0.43 percent at 17,784, S&P 500 futures were down 0.49 percent at 2,065.25 and Nasdaq 100 futures were down 0.42 percent at 4,354.
** SYNTA PHARMACEUTICALS CORP, Monday close $2.33, -18.45 pct premarket
The drug developer said it would commence a public offering of common shares, but did not say when the offering would be completed or provide any details on the number of shares or price.
** REYNOLDS AMERICAN INC, Monday close $69.47, -2.02 pct premarket
** LORILLARD INC, Monday close $66.42, -3.49 pct premarket
The Federal Trade Commission staff is recommending a suit to block the $27 billion merger of the second- and third-biggest cigarette makers, Reynolds American and Lorillard, the New York Post reported, citing a well-placed DC source not working on the case said. (bit.ly/1xuMHLZ)